SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-16-647419
Filing Date
2016-07-13
Accepted
2016-07-13 17:30:33
Documents
2
Group Members
QVT ASSOCIATES GP LLCQVT FINANCIAL GP LLCQVT FUND V LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d206436dsc13d.htm SC 13D 83228
2 EX-1 d206436dex991.htm EX-99.1 13807
  Complete submission text file 0001193125-16-647419.txt   98864
Mailing Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036
Business Address 1177 AVENUE OF THE AMERICAS 9TH FLOOR NEW YORK NY 10036 212-705-8800
QVT Financial LP (Filed by) CIK: 0001290162 (see all company filings)

IRS No.: 113694008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11 441-295-5950
Axovant Sciences Ltd. (Subject) CIK: 0001636050 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-88883 | Film No.: 161766220
SIC: 2834 Pharmaceutical Preparations